ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.335
+0.025 (1.91%)
Oct 19, 2026, 12:40 PM EDT - Market open

ProQR Therapeutics Revenue

ProQR Therapeutics had revenue of 8.76M EUR in the quarter ending June 30, 2026, with 120.35% growth. This brings the company's total for the last twelve months to 18.42M, up 7.49% year-over-year. In the year 2025, ProQR Therapeutics had annual revenue of 16.35M, down -16.36%. That makes ProQR Therapeutics the 33,515th largest company in the world by revenue and 4,404th in the United States.

Revenue (ttm)
18.42M EUR
Revenue Growth
+7.49%
P/S Ratio
8.78
Revenue / Employee
98,730 EUR
Employees
187
Market Cap
188.40M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202516.35M-3.20M-16.36%
Dec 31, 202419.55M10.02M105.20%
Dec 31, 20239.53M5.17M118.51%
Dec 31, 20224.36M1.98M83.31%
Dec 31, 20212.38M-7.07M-74.84%
Dec 31, 20209.45M7.52M388.98%
Dec 31, 20191.93M-3.83M-66.45%
Dec 31, 20185.76M4.27M285.35%
Dec 31, 20171.50M-333.00K-18.22%
Dec 31, 20161.83M-1.41M-43.49%
Dec 31, 20153.24M2.92M933.55%
Dec 31, 2014313.00K197.00K169.83%
Dec 31, 2013116.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Compugen74.00M
Invivyd58.37M
Sutro Biopharma45.70M
Alpha Cognition15.26M
Evommune10.00M
Camp4 Therapeutics4.22M
Cartesian Therapeutics1.48M
InflaRx-11.54K
Revenue Rankings